256th ENMC international workshop: Myositis specific and associated autoantibodies (MSA-ab): Amsterdam, The Netherlands, 8-10 October 2021

•Consensus regarding the clinical indications that ask for detection of MSA.•Consensus regarding the optimal testing strategy for patients suspected of IIM.•Consensus on the format for reporting results to the clinician in order to enable optimal interpretation.•Proposition of the research agenda to...

Full description

Saved in:
Bibliographic Details
Published in:Neuromuscular disorders : NMD 2022-07, Vol.32 (7), p.594-608
Main Authors: Damoiseaux, Jan, Mammen, Andrew L., Piette, Yves, Benveniste, Olivier, Allenbach, Yves, Bonroy, Carolien, Bossuyt, Xavier, Boyer, Olivier, Casciola-Rosen, Livia, Chinoy, Hector, Damoiseaux, Jan , de Groot, Ingrid, Lundberg, Ingrid E., Mammen, Andrew, McHugh, Neil, Mischke, Roland, Pruijn, Ger, Ronnelid, Johan, Selva-O'Callaghan, Albert, Stenzel, Werner, Tansley, Sarah, Vencovsky, Jiri, Wang, Guochun
Format: Article
Language:English
Subjects:
Autoantibodies
Harmonization
Idiopathic inflammatory myopathy
Life Sciences
Myositis-specific autoantibodies
Test-characteristics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Consensus regarding the clinical indications that ask for detection of MSA.•Consensus regarding the optimal testing strategy for patients suspected of IIM.•Consensus on the format for reporting results to the clinician in order to enable optimal interpretation.•Proposition of the research agenda to obtain reliable data on the test-characteristics of the immuno-assays for MSA.
ISSN:0960-8966
1873-2364
1873-2364
DOI:10.1016/j.nmd.2022.05.011